Episode

Federal Rescheduling and the BUILD Act: Capitol Hill’s Shift on Cannabis Reform

Podcast
Blunt Business
Published
May 27, 2026
Duration seconds
1485
Processing state
not_requested
Canonical source
https://cannabisradio.com/audio/7919
Audio
https://audio3.redcircle.com/episodes/77f2c599-b419-474c-82a2-4eb9e0c211e7/stream.mp3
JSON
/v1/public/podcasts/blunt-business-326858/episodes/federal-rescheduling-and-the-build-act-capitol-hill-s-shift-on-cannabis-reform
Markdown
/podcast/blunt-business-326858/federal-rescheduling-and-the-build-act-capitol-hill-s-shift-on-cannabis-reform.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/blunt-business-326858/episodes/federal-rescheduling-and-the-build-act-capitol-hill-s-shift-on-cannabis-reform/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/blunt-business-326858/federal-rescheduling-and-the-build-act-capitol-hill-s-shift-on-cannabis-reform.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Blunt Business zeroes in on major developments unfolding on the congressional front. It highlights how impending federal rescheduling could significantly alter medical cannabis policies within the Veterans Administration, potentially expanding access for military veterans by allowing VA doctors to discuss and document use, as well as refer patients to state-approved programs. Additionally, we break down the bipartisan BUILD Act (Building Unrivaled Infrastructure and Long-Term Development Act), a piece of transportation legislation moving toward a House floor vote. The bill directives mandate federal agencies to invest $110 million to research poly-substance impairment and establish standardized, evidence-based driving limits, addressing the long-standing scientific flaws and regional inconsistencies currently plaguing roadside testing. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy